Medtronic beats quarterly estimates on robust demand for heart devices

J.P. Morgan ⁠analyst Robbie Marcus said he expects “to see some scrutiny,” as the outlook was ​reiterated despite the quarterly beat and an around 100-basis-point benefit from foreign exchange, adding ​that this implies lower underlying growth for the fourth quarter.

Leave a Reply